Publications for Carl Hamby hamby@nymc.edu

Chu, Y., Lee, F., Hamby, C., Misarti, J., Hang, B., Ayello, J., . . . Cairo, M. (2016). Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by Alt-803, an IL-15 superagonist. Experimental Hematology, 44(9), S64. doi:10.1016/j.exphem.2016.06.107

Mehta, B., Militano, O., Ozkaynak, M. F., van de Ven, C., Nickerson, B. A., Hamby, C.,. . . Cairo, M. S. (2016). Mycophenolate mofetil (MMF) administered every eight hours with tacrolimus is efficacious in acute graft versus host disease (aGVHD) prophylaxis in childhood, adolescent and young adult (CAYA) allogeneic hematopoietic progenitor transplant (ALLOHPT) recip. Pediatric Blood & Cancer, 63(Suppl S1), S97.

Huang, X., Park, H., Greene, J., Moy, F., Hamby, C. V., Cairo, M. S., . . . Zhou, X. (2015). IGF1R- and ROR1-specific CAR T cells as a potential therapy for high risk sarcomas. PLoS One, 10(7), [Article: e0133152]. doi:10.1371/journal.pone.0133152

Huang, X., Greene, J., Chu, Y., Hamby, C., Cairo, M. S., . . . Zhou, X. (2014). Chimeric antigen receptor (CAR) T cell immunotherapy for poor risk sarcomas. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S184-S185.

Weinstein, D., Leininger, J., Hamby, C., & Safai, B. (2014). Diagnostic and prognostic biomarkers in melanoma. Journal of Clinical and Aesthetic Dermatology, 7(6), 13-24.  PMCID: PMC4086529

Zanganeh, S., Xu, Y., Hamby, C. V., Backer, M. V., Backer, J. M., & Zhu, Q. (2013). Enhanced fluorescence diffuse optical tomography with indocyanine green-encapsulating liposomes targeted to receptors for vascular endothelial growth factor in tumor vasculature. Journal of Biomedical Optics, 18(12), 126014. doi:10.1117/1.JBO.18.12.126014